Dr. Michael Stierstorfer, Clinical Associate Professor of Dermatology at the University of Pennsylvania School of Medicine and founder of East Penn Dermatology, has led efforts to teach clinicians about Type IV allergies as potential causes for common gastrointestinal diseases such as IBS, coining the term "allergic contact enteritis." He joins Dr. Brian McDonough to discuss intersections between dermatology and gastroenterology in the study of hypersensitivity reactions.
Allergic Contact Enteritis: Where Dermatology Meets Gastroenterology
Dr. Michael Stierstorfer discusses intersections between dermatology and gastroenterology in the study of hypersensitivity reactions.
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Dr. Michael Stierstorfer, Clinical Associate Professor of Dermatology at the University of Pennsylvania School of Medicine and founder of East Penn Dermatology, has led efforts to teach clinicians about Type IV allergies as potential causes for common gastrointestinal diseases such as IBS, coining the term "allergic contact enteritis." He joins Dr. Brian McDonough to discuss intersections between dermatology and gastroenterology in the study of hypersensitivity reactions.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE Broadcast Replay
Love Story: Lipid Education for Women’s Heart Health
0.50 credits
<p>Love Story: Lipid Education for Women’s Heart Health</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
MinuteCE®
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
1.25 credits
<p>Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy</p>
MinuteCE®
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
0.50 credits
<p>What do we know now that could have changed the history of CETP inhibition?: genetics and biology </p>
On the Frontlines of Food Allergies
Insights on Food Allergy Anxiety: Understanding and Supporting Patients
<p>Insights on Food Allergy Anxiety: Understanding and Supporting Patients</p>
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
<p>Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids</p>
Cardiology
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
<p>Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF</p>
Cardiology
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
<p>Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?